A Republican bill with 6 Democratic cosponsors · See all 9 cosponsors
Last activity — Referred to the House Committee on Energy and Commerce.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill, known as the "SAFE Sunscreen Standards Act," aims to amend the Federal Food, Drug, and Cosmetic Act. The purpose is to improve the regulatory review process for determining the safety and effectiveness of nonprescription sunscreen active ingredients. It directs the Secretary to establish new standards for evaluating these ingredients. The bill also encourages the use of nonclinical testing alternatives to animal testing. Additionally, it directs the final administrative order on pending submissions to account for historical data of safe use.
Yes· 3 of 7
- Scored +5
Does this better protect air, water and wildlife?
The bill encourages non-animal testing methods, reducing the environmental and ethical impact of animal research.
- Scored +4
Would people in their twenties and thirties be better off under this?
The bill helps prevent skin cancer, which the text notes is highly prevalent in young adults.
- Scored +4
Does this make health care easier to get in general?
The bill improves access to preventative healthcare tools by modernizing the sunscreen ingredient approval process.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
-
Improved access to new sunscreen ingredients: The Secretary is tasked with establishing standards that allow for the use of real-world evidence, observational studies, and other scientific approaches instead of just traditional clinical tests (Section 3, Section 505G(r)(1)(B)).
-
Reduction in animal testing: The Secretary must consider nonclinical tests and other alternatives to animal testing when evaluating sunscreen active ingredients (Section 3, Section 505G(r)(2)(A)).
-
Safety through comprehensive evaluation: The standards established must ensure consumer safety through a comprehensive evaluation of scientific evidence (Section 3, Section 505G(r)(1)(A)).
-
Use of historical safety data: The final administrative order for pending submissions must account for historical data that shows certain sunscreen active ingredients have been previously accepted for marketing in the United States (Section 4).
Potential Negative Impacts for People
- No specific negative impacts are explicitly mentioned in the text provided.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would people in their twenties and thirties be better off under this? — The bill helps prevent skin cancer, which the text notes is highly prevalent in young adults. Would business owners be better off under this? — The bill helps business owners by streamlining the regulatory pathway for sunscreen products.
- Environment Energy And Infrastructure
- Does this better protect air, water and wildlife? — The bill encourages non-animal testing methods, reducing the environmental and ethical impact of animal research.
- Healthcare
- Does this make health care easier to get in general? — The bill improves access to preventative healthcare tools by modernizing the sunscreen ingredient approval process.
- Economy And Finance
- Does this give people more protection from unfair business practices? — The bill improves consumer protection by streamlining the approval of safe and effective sunscreen ingredients.
- Governance And Ideology
- Does this make what the government does easier for the public to see? — The bill mandates annual reports to Congress and public publication of findings, increasing transparency. Does this give the federal government more power? — The bill increases federal authority by refining FDA regulatory standards.
- 12/18/2025
- 1 Cosponsor added.
- 11/20/2025
- 1 Cosponsor added.
- 10/17/2025
- 2 Cosponsors added.
- 9/30/2025
- 1 Cosponsor added.
- 8/15/2025
- 1 Cosponsor added.
- 6/3/2025
- Referred to the House Committee on Energy and Commerce.
- 3 Cosponsors added.
- Introduced in House
Jake AuchinclossDemocrat · Massachusetts
Debbie DingellDemocrat · Michigan
Craig GoldmanRepublican · Texas
David JoyceRepublican · Ohio
John JamesRepublican · Michigan
Joe NeguseDemocrat · Colorado
Deborah RossDemocrat · North Carolina
Eric SwalwellDemocrat · California
Eugene VindmanDemocrat · Virginia